Medical Developments International (MDI)
Pharmaceutical ManufacturingVictoria, Australia51-200 Employees
MDI is an Australian pharmaceutical manufacturer focused on emergency medical solutions, with products spanning pain management, asthma, resuscitation, and veterinary equipment. It has produced Penthrox, a pain relief product that has been widely adopted in medical settings. The company operates from its head office and manufacturing facilities in Melbourne, Victoria, and is publicly listed on the Australian Securities Exchange. It adheres to Good Manufacturing Practices and ISO 13485 for several products, with some items CE marked for sale in the European Community. MDI serves healthcare professionals and patients, providing solutions aimed at improving patient outcomes in emergency and acute care contexts, with a history dating back to 1971 and activity in both human and veterinary medicine. In 2024, the company released its Q3 FY24 quarterly report.